NKTR

NEKTAR THERAPEUTICS

Healthcare | Small Cap

-$2.06

EPS Forecast

$10.27

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$2.06

Revenue Forecast:

$10.27

EPS Surprise Forecast:

$0.099

Revenue Surprise Forecast:

$0

Post-release price volatility - Very high

Post-release Overnight Move:

±11.4%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

61%

Probability of beating revenue consensus:

52%

Probability of beating both EPS & revs consensus:

38%

Probability of missing both EPS & revs consensus:

25%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.54

Earnings volatility

EPS standard deviation:

$0.97

Revenue standard deviation:

$8

As % of share price:

2.37% EXTREME UNCERTAINTY

As % of market cap:

0.58% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.84

Revenue 95th %ile:

$20

EPS 75th %ile:

-$1.73

Revenue 75th %ile:

$13

EPS 25th %ile:

-$2.34

Revenue 25th %ile:

$8

EPS 5th %ile:

-$3.17

Revenue 5th %ile:

$2

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$29

Bid-ask per Share:

$0.12